Article
The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.
The Journal of clinical endocrinology and metabolism - 1 Jul 2009
Vargiolu Manuela, Fusco Daniela, Kurelac Ivana, Dirnberger Dietmar, Baumeister Ralf, Morra Isabella, Melcarne Antonio, Rimondini Roberto, Romeo Giovanni, Bonora Elena
Abstract excerpt
CONTEXT: RET is a tyrosine kinase transmembrane receptor expressed in two main alternative isoforms: RET9 and RET51. RET transduces a positive signal leading to survival, differentiation, or migration in the presence of its ligand glial cell line-derived neurotrophic factor, whereas in its absence a proapoptotic fragment that initiates a negative signaling for apoptosis is generated. The signal transduction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
